1
|
Chattaraj A, Selvam TP. Comparison of 126 MeV antiproton and proton—a FLUKA-based microdosimetric approach. Phys Med Biol 2022; 67. [DOI: 10.1088/1361-6560/ac88b4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2022] [Accepted: 08/10/2022] [Indexed: 11/11/2022]
Abstract
Abstract
Objective. This study aims at comparing dosimetric parameters of 126 MeV antiprotons and protons using microdosimetric approach. Approach. Microdosimetric distributions of 126 MeV proton and antiproton beams at 1 μm site size are calculated using the Monte Carlo-based FLUKA code. The distributions are calculated at various depths along the central axis in water phantom as well as at different off-axis locations. The study also includes calculations of secondary radiations produced by antiprotons and protons. Mean quality factor,
Q
¯
is calculated using the ICRP 60 and ICRU 40 recommendations. The Relative Biological Effectiveness (RBE) of HSG tumour cell at 10% survival level is calculated based on Microdosimetric Kinetic Model. Main results.
Q
¯
I
C
R
P
,
Q
¯
ICRU
and RBE for antiprotons are higher by a factor of about 3.60, 3.41 and 1.24, respectively, at Bragg-peak and higher by a factor of about 1.41, 1.76 and 1.05, respectively, at plateau region of depth-dose profile when compared to protons. At 15 cm depth along the central axis,
Q
¯
ICRP
,
Q
¯
ICRU
and RBE for protons are higher by a factor of about 1.42, 1.66 and 1.26, respectively, when compared to antiprotons. At the off-axis distance (Ld
) of 6 cm (at 11.5 cm depth in water),
Q
¯
ICRP
and
Q
¯
ICRU
of protons are higher than that of antiproton whereas the trend is opposite at off-axis distance of 4 cm. At Ld
= 4 cm (at 11.5 cm depth in water), RBE of antiprotons is higher by about 4% than protons whereas at Ld
= 6 cm, RBE of protons is higher by about 13% than antiprotons. Significance. The study shows that antiproton radiotherapy is advantageous as compared to protons considering enhancements in the absorbed dose and RBE-weighed dose values at the Bragg-peak.
Collapse
|
2
|
Shmatov ML. An expected increase in the efficiency of antiproton cancer therapy with the use of gold nanoparticles. Phys Med Biol 2015; 60:N383-90. [DOI: 10.1088/0031-9155/60/20/n383] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
3
|
|
4
|
Paganetti H, Goitein M, Parodi K. Spread-out antiproton beams deliver poor physical dose distributions for radiation therapy. Radiother Oncol 2010; 95:79-86. [DOI: 10.1016/j.radonc.2009.03.020] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2008] [Revised: 03/11/2009] [Accepted: 03/14/2009] [Indexed: 11/29/2022]
|